BRIEF-Tigenix reconfirms its strategic focus on its allogeneic stem cell platforms – Reuters
|
BRIEF-Tigenix reconfirms its strategic focus on its allogeneic stem cell platforms
Reuters July 5 Tigenix Nv : * Reconfirms its strategic focus on its allogeneic stem cell platforms. * Announced initiation of withdrawal of Marketing Authorization for ChondroCelect due to commercial reasons Source text for Eikon: Further company coverage … |
